Global Mammalian Transient Protein Expression Market Set for Exponential Growth 8.5% CAGR through 2023 to 2033

Mammalian Transient Protein Expression Market
Mammalian Transient Protein Expression Market

According to the latest market analysis conducted by Future Market Insights (FMI), the global mammalian transient protein expression market is poised for substantial growth, projecting a robust Compound Annual Growth Rate (CAGR) of 8.5% from 2023 to 2033. The market, valued at USD 697.2 million in 2023, is expected to surge to USD 1581.6 million by the end of the forecast period.

Mammalian Transient Protein (MTP) expression, a pivotal component within mammalian cells, is instrumental in essential cellular processes such as DNA replication, cell division, and protein synthesis. Moreover, MTP plays a critical role in apoptosis, the regulated process of cellular self-destruction.

Get Sample Report Visit: https://www.futuremarketinsights.com/reports/sample/rep-gb-12807

“This growth trajectory reflects the increasing demand for advanced cellular research tools and biopharmaceutical development,” remarked a FMI. “The application of mammalian transient protein expression in biotechnology and pharmaceutical industries underscores its significance in enhancing therapeutic protein production and biologics development.”

Key Takeaways: Mammalian Transient Protein Expression Market

  • The global market is expected to reach US$ 1.58 billion by 2033, growing at a CAGR of 8.5% (FMI).
  • The U.S. market is anticipated to see a CAGR of 8.4%, driven by rising chronic diseases like cancer.
  • The Chinese market is projected to grow at a CAGR of 9.0% due to increasing research activity and domestic pharmaceutical companies.
  • Canada is likely to record a CAGR of 9.0% over the forecast period.
  • Rising government support for research is likely to fuel market growth across regions.

Customization with Our Report: https://www.futuremarketinsights.com/customization-available/rep-gb-12807

Competitive Landscape:

Significant elements of the mammalian transient protein expression market include product development and market expansion. Consequently, market participants stand to gain a larger share of global revenue in this sector. This trend is anticipated to facilitate the enhancement of product portfolios and the augmentation of market penetration rates.

Key Market Developments:

  • In April 2022, Thermo Fisher Scientific introduced the Gibco CTS TrueCut Cas9 Protein, manufactured according to GMP standards.
  • In October 2020, Merck KgaA announced an expansion initiative, marked by the inauguration of a new membrane production facility in Darmstadt, Germany. This expansion aimed to bolster the production capacity of Millipore Express® membranes.

Key Companies Profiled:

  • Thermofisher Scientific
  • Merck KGaA
  • Promega Corporation
  • Lonza
  • Agilent Technologies, Inc.
  • Bio-Rad
  • Qiagen
  • Takara Bio
  • HiMedia Laboratories.
  • Mirus
  • Sino Biological, Inc.

Key Market Segments Covered in Mammalian Transient Protein Expression Industry Research

By Product:

  • Instruments
  • Expression Vector
  • Reagents & Consumables
  • Cell Lines
    • Chinese Hamster Ovary Cells (CHO)
    • Human embryonic kidney 293 (HEK 293) cells
    • Others

By Application:

  • Bio-production
    • Antibody Production
    • Therapeutic protein production
  • Functional Cell-Based Assays
  • Academic Research
  • Others

By End User:

  • Contract Research Organization
  • Biopharmaceutical Companies
  • Academic & Research Institutes

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East and Africa (MEA)

A Full Report Analysis: https://www.futuremarketinsights.com/checkout/12807

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: 
sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

About the Author

Nikhil Kaitwade

Associate Vice President at Future Market Insights, Inc. has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil & Gas, and Service industries.
His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.
Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may also like these